newsfilter
← Latest News
Business Wire·

Teva and Bioeq Announce Commercial Partnership for Biosimilar

Agreement includes commercializing biosimilar candidate of ophthalmology drug ranibizumab (Lucentis®) in Europe, Canada, Israel and global markets Teva Pharmaceutical Industries Ltd. (NYSE:AND) and Bioeq AG ("Bioeq") today announced that they have e